1. Home
  2. CYTK vs ALK Comparison

CYTK vs ALK Comparison

Compare CYTK & ALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$64.98

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Alaska Air Group Inc.

ALK

Alaska Air Group Inc.

HOLD

Current Price

$39.39

Market Cap

6.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
ALK
Founded
1997
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.4B
IPO Year
2004
2003

Fundamental Metrics

Financial Performance
Metric
CYTK
ALK
Price
$64.98
$39.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
12
Target Price
$88.94
$64.50
AVG Volume (30 Days)
1.8M
5.0M
Earning Date
05-05-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.83
Revenue
$13,368,000.00
$10,426,000,000.00
Revenue This Year
$6.88
$10.54
Revenue Next Year
$308.26
$5.44
P/E Ratio
N/A
$48.06
Revenue Growth
N/A
8.09
52 Week Low
$29.31
$33.03
52 Week High
$70.98
$65.35

Technical Indicators

Market Signals
Indicator
CYTK
ALK
Relative Strength Index (RSI) 54.07 46.38
Support Level $59.12 $37.16
Resistance Level $67.94 $40.62
Average True Range (ATR) 2.25 2.02
MACD 0.26 0.79
Stochastic Oscillator 61.73 62.04

Price Performance

Historical Comparison
CYTK
ALK

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon, in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements. The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary, and Mileage Plan passenger revenue.

Share on Social Networks: